Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim

Abstract Congenital amegakaryocytic thrombocytopenia (CAMT) is an inherited disorder characterized at birth by thrombocytopenia with reduced megakaryocytes, which evolves into generalized bone marrow aplasia during childhood. Although CAMT is genetically heterogeneous, mutations of MPL, the gene enc...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Alessandro Pecci, Iman Ragab, Valeria Bozzi, Daniela De Rocco, Serena Barozzi, Tania Giangregorio, Heba Ali, Federica Melazzini, Mohamed Sallam, Caterina Alfano, Annalisa Pastore, Carlo L Balduini, Anna Savoia
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer Nature 2017-11-01
Serija:	EMBO Molecular Medicine
Teme:	congenital amegakaryocytic thrombocytopenia MPL mutation romiplostim thrombopoietin
Online dostop:	https://doi.org/10.15252/emmm.201708168
Oznake:	Označite Brez oznak, prvi označite!